Bortezomib Alpha-Medical 3,5 mg prašak za otopinu za injekciju
| Name | Bortezomib Alpha-Medical 3,5 mg prašak za otopinu za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-781716538 |
| Active Substance | bortezomibum |
| Composition | svaka bočica sadrži 3,5 mg bortezomiba (u obliku estera boronatne kiseline i manitola) |
| Pharmaceutical Form | prašak za otopinu za injekciju |
| Packaging [MA Number for Packaging] | 1 bočica s praškom, u kutiji [HR-H-781716538-01] |
| Manufacturer | PharmIdea SIA, Olaine, Latvija |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 24.01.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/232 |
| Registration Number | 381-12-01/70-20-03 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01XG01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Brošura s uputstvima o pripremi, doziranju i primjeni, verzija 3 Grafikon sheme liječenja, verzija 2 Pomična mjerka s uputama za doziranje, verzija 2 Poster s uputstvima za pripremu lijeka, verzija 3 |
